ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Gori To Leave NCI For Job At Franklin Institute

April 18, 1980

HHS Forms Office for Recovery Act

March 13, 2009

President Obama Names Six NCAB Members

December 7, 2012

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

AACR, ASCO Continue Growth, Drop Idea Of “Cancer Week”

July 1, 1988

NCI Programs to Average Eight Percent Increase Over ’87 Under House Total, Bit Some Would Vary

August 14, 1987